- Daily & Weekly newsletters
- Buy & download The Bulletin
- Comment on our articles
New blood test predicts seriousness of peanut allergy
Scientists at Antwerp University (UAntwerp) and Antwerp University Hospital (UZA) have developed a blood test to predict the seriousness of a person’s peanut allergy.
A peanut allergy is relatively common, among both children and adults, but in different gradations. “Some people will have harmless symptoms, like an itchy throat,” said researcher Margriet Faber, of UAntwerp and UZA. “But a peanut allergy can also trigger serious and even life-threatening symptoms like severe swelling of the face, a fall in blood pressure and shortness of breath.”
People who are severely allergic should avoid peanuts, even in very small amounts. “That isn’t easy and can be very stressful for patients and family members,” said Faber. “That’s why it’s essential to correctly estimate the seriousness of the allergy.”
Results of the Antwerp study show that different antibodies present in the body point to different levels of allergic reactions. Antibodies against the protein Ara h 8 are often related to mild symptoms, while antibodies against the Ara h 2 protein were detected in 94% of patients with a serious allergy.
The test works especially well on children younger than seven, Faber said.








